ReviewBMC nephrology2023
Home hemodialysis technique survival: insights and challenges.
Review in BMC nephrology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Article
- KDIGO Workshop Report on the Implementation and Expansion of Home Hemodialysis in East Asia: A Focus on Hong Kong, Japan, Korea, and Taiwan.Kidney international reports · 2026Article
- Hemodiafiltration at Home: A Single Centre Experience Reviewing Safety, Efficacy, and Implementation.Hemodialysis international. International Symposium on Home Hemodialysis · 2026Article
- Quality Metrics in Dialysis: It Takes a Village.Advances in kidney disease and health · 2025Review
- A Home Hemodialysis Objective Structured Clinical Examination for Formative Assessment of Nephrology Fellows.Clinical journal of the American Society of Nephrology : CJASN · 2025Article
- Efficacy of slow daily home hemodialysis with internal convection on removal of uremic toxins using the Physidia S3 monitor.Scientific reports · 2025Article
- Population-level barriers to home hemodialysis implementation: a public health systems analysis of adoption readiness, health equity, and policy implications in China.Frontiers in public health · 2025Article
- The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease.Biomolecules · 2024Review
- Innovative Journeys to Motherhood: Option of Home Dialysis for Women With Advanced Kidney Disease or Kidney Failure.Kidney international reports · 2024Article
- Long-term survival of patients receiving home hemodialysis with self-punctured arteriovenous access.PloS one · 2024Observational
- Severe acute respiratory infections: An epidemiological analysis of surveillance data in Bahrain, 2018-2022.Qatar medical journal · 2024Article
- Position Statement of the Brazilian Society of Nephrology on Home Hemodialysis.Jornal brasileiro de nefrologiaArticle
- Safety and Efficacy of the First Mobile Intelligent Hemodialysis Platform in Mainland China: Protocol for a Single-Center Prospective Exploratory Study in Maintenance Hemodialysis Patients.Kidney diseases (Basel, Switzerland)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Home hemodialysis (HHD) offers several clinical, quality of life and cost-saving benefits for patients with end-stage kidney disease. While uptake of this modality has increased in recent years, its prevalence remains low and high rates of discontinuation remain a challenge. This comprehensive narrative review aims to better understand what is currently known about technique survival in HHD patients, elucidate the clinical factors that contribute to attrition and expand on possible strategies to prevent discontinuation. With increasing efforts to encourage home modalities, it is imperative to better understand technique survival and find strategies to help maintain patients on the home therapy of their choosing. It is crucial to better target high-risk patients, examine ideal training practices and identify practices that are potentially modifiable to improve technique survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.